Circio Holding is a pharmaceutical company. The company's specialist expertise is in targeted immunotherapy used in the treatment of cancer patients. The company's operations consist of research and development and the pharmaceuticals are currently sold under separate brands. Several partnerships in the market have been entered to strengthen cooperation in the development of new immunotherapy. The company was founded in 2010 and is headquartered in Lysaker.